We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+40.86%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$103M
AUM Growth
+$18.3M
(+22%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
11.77%
Top 10 Holdings %
Top 10 Hldgs %
44.11%
Holding
78
New
16
Increased
27
Reduced
9
Closed
5
Top Buys
| 1 |
ARKO Corp
ARKO
|
+$3.18M |
| 2 |
Coherus Oncology
CHRS
|
+$1.48M |
| 3 |
CVS Health
CVS
|
+$1.42M |
| 4 |
B
Barrick Mining
B
|
+$911K |
| 5 |
Talos Energy
TALO
|
+$808K |
Top Sells
| 1 |
Preformed Line Products
PLPC
|
+$1.53M |
| 2 |
OneSpan
OSPN
|
+$1.23M |
| 3 |
Cytokinetics
CYTK
|
+$925K |
| 4 |
TAST
Carrols Restaurant Group, Inc.
TAST
|
+$793K |
| 5 |
ARKOW
ARKO Corp Warrant
ARKOW
|
+$597K |
Sector Composition
| 1 | Healthcare | 42% |
| 2 | Industrials | 9.41% |
| 3 | Energy | 9.38% |
| 4 | Financials | 8.51% |
| 5 | Consumer Discretionary | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
51
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $553K | 0.54% |
250,000
-200,000
| -44% | -$415K |
|
52
Evolus
EOLS
$392M
| $545K | 0.53% |
+75,000
| New | +$647K |
|
53
Curis
CRIS
$9.22M
| $457K | 0.45% |
1,375
| – | – |
|
54
PagerDuty
PD
$829M
| $450K | 0.44% |
+20,000
| New | +$556K |
|
55
Nektar Therapeutics
NKTR
$2.31B
| $431K | 0.42% |
50,000
+23,333
| +87% | +$249K |
|
|
KRON
56
DELISTED
Kronos Bio
KRON
| $430K | 0.42% |
250,000
+70,000
| +39% | +$111K |
|
57
Lantern Pharma
LTRN
$39.6M
| $423K | 0.41% |
75,000
+15,000
| +25% | +$77.5K |
|
58
Gain Therapeutics
GANX
$71.7M
| $403K | 0.39% |
90,000
| – | – |
|
|
APLT
59
DELISTED
Applied Therapeutics
APLT
| $384K | 0.37% |
+300,000
| New | +$398K |
|
|
BCEL
60
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $343K | 0.33% |
350,000
+75,000
| +27% | +$77.2K |
|
|
61
Cytokinetics
CYTK
$11.2B
| $326K | 0.32% |
10,000
-25,000
| -71% | -$925K |
|
62
Eledon Pharmaceuticals
ELDN
$310M
| $322K | 0.31% |
234,803
+3
| +0% | +$6 |
|
|
NEUE
63
DELISTED
NeueHealth
NEUE
| $314K | 0.31% |
25,715
+19,465
| +311% | +$258K |
|
64
Organon & Co
OGN
$3.54B
| $312K | 0.3% |
+15,000
| New | +$326K |
|
65
Edesa Biotech
EDSA
$66.2M
| $304K | 0.3% |
53,571
+7,142
| +15% | +$47.5K |
|
66
Newell Brands
NWL
$2.19B
| $261K | 0.25% |
+30,000
| New | +$298K |
|
67
Smith Micro Software
SMSI
$14.5M
| $250K | 0.24% |
5,625
+1,625
| +41% | +$77.2K |
|
68
Coya Therapeutics
COYA
$114M
| $244K | 0.24% |
+60,000
| New | +$278K |
|
|
CADE
69
DELISTED
Cadence Bank
CADE
| $196K | 0.19% |
+10,000
| New | +$197K |
|
|
ASRT
70
DELISTED
Assertio
ASRT
| $136K | 0.13% |
+1,667
| New | +$155K |
|
71
Femasys
FEMY
$10.8M
| $123K | 0.12% |
12,069
| – | – |
|
|
PVLA
72
Palvella Therapeutics
PVLA
$2.18B
| $91K | 0.09% |
+6,875
| New | +$417K |
|
|
NBSE
73
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $11K | 0.01% |
6,000
| – | – |
|
|
ADVM
74
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-37,500
| Closed | -$269K |
|
|
ARKOW
75
DELISTED
ARKO Corp Warrant
ARKOW
| – | – |
-400,000
| Closed | -$597K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM